Latest News

Date Title Topic
27 Mar 2014 ELCC 2014 News: A Meta-Analysis of Platinum-Based vs. Single Agent Chemotherapy in NSCLC Patients with Performance Status 2 Cancer in Special Situations - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: Salvage Therapy With Paclitaxel and Bevacizumab in Patients with Refractory Relapsed SCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: Efficacy and Safety of Targeted Therapy in Elderly Patients With Lung Cancer Adenocarcinoma Cancer in Special Situations - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: PD-L1 Expression and Association with Survival in Mesothelioma Pathology/Molecular biology - Lung and other thoracic tumours - Immuno-oncology
27 Mar 2014 ELCC 2014 News: PD-L1 and PD-1 Expression in a Cohort of Molecularly Selected NSCLC Patients Pathology/Molecular biology - Lung and other thoracic tumours - Immuno-oncology
27 Mar 2014 ELCC 2014 News: Diagnosis and Targeting Lung Adenocarcinoma with RET Fusion Pathology/Molecular biology - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: QoL in ENSURE Study of First-Line Erlotinib vs. Gemcitabine/Cisplatin in Asian Patients with EGFR Mutation-Positive NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: Phase I Study of CO-1686 in Patients with EGFR Mutated Recurrent, Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Mar 2014 ELCC 2014 Press Release: Immunotherapy Data Heralds New Era of Lung Cancer Treatment Lung and other thoracic tumours - Immuno-oncology
ESMO Booth
24 Mar 2014 EMA Recommends Granting a Conditional Marketing Authorisation for Vintafolide for the Treatment of Platinum-resistant Ovarian Cancer that Expresses the Folate Receptor Personalised medicine - Gynaecologic malignancies - Anticancer agents & Biologic therapy
20 Mar 2014 Precision Oncology 3.0 Personalised medicine
20 Mar 2014 Coordinating Action Systems Medicine: Systems Biology Application Across Europe Personalised medicine
19 Mar 2014 Idelalisib in Relapsed Indolent Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy